Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors, studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes. With an extended half-life of approximately 6 days, this peptide enables convenient once-weekly subcutaneous dosing with a gradual titration protocol to optimize tolerability

• Reconstitute: Add 2.0 mL bacteriostatic water → 10.0 mg/mL concentration for optimal weekly doses.
• Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
• Easy measuring: With the Epipen turn the dial to 30 clicks. This is the starting dose equals to 20 Units on a insulin 1 ml needle.
• Storage: Reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).
• The starter kits contain:
• 1 x Retatrutide Vial 20mg vial
• 1x Cagrilintide 5mg
• 1 x Epipen
• 10 x Epipen Needles
• 10 x Alcohol Wipes
• 8-9 weeks dosage at 2mg
• Only need to buy the Pen once and order Reta refill when your vial is empty.
• How Cagrilintide Works
  • Mechanism: It mimics amylin, a natural pancreatic hormone co-secreted with insulin.
  • Appetite Control: It targets areas in the hindbrain and brainstem to promote satiety, slow gastric emptying, and reduce food intake.
  • Dual Action: Unlike GLP-1 receptor agonists (such as semaglutide) that work via incretin pathways, cagrilintide acts through a completely separate amylin and calcitonin receptor route